Related Experiment Video
Updated: Aug 10, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response
Harish Shankaran1, H Steven Wiley, Haluk Resat
1Pacific Northwest National Laboratory, Richland, WA, USA.
Abstract:
The human epidermal growth factor receptor (HER/ErbB) system comprises the epidermal growth factor receptor (EGFR/HER1) and three other homologs, namely HERs 2-4. This receptor system plays a critical role in cell proliferation and differentiation and receptor overexpression has been associated with poor prognosis in cancers of the epithelium. Here, we examine the effect of coexpressing varying levels of HERs 1-3 on the receptor dimerization patterns using a detailed kinetic model for HER/ErbB dimerization and trafficking. Our results indicate that coexpression of EGFR with HER2 or HER3 biases signaling to the cell surface and retards signal downregulation. In addition, simultaneous coexpression of HERs 1-3 leads to an abundance of HER2-HER3 heterodimers, which are known to be potent inducers of cell growth and transformation. Our new approach to use parameter dependence analysis in experimental design reveals that measurements of HER3 phosphorylation and HER2 internalization ratio may prove to be especially useful for the estimation of critical model parameters. Further, we examine the effect of receptor dimerization patterns on biological response using a simple phenomenological model. Results indicate that coexpression of EGFR with HER2 and HER3 at low to moderate levels may enable cells to match the response of a high HER2 expresser.
Insights
Coexpressing human epidermal growth factor receptors (HERs) 1-3 influences cell signaling pathways. This study reveals that specific HER combinations, particularly HER2-HER3 heterodimers, promote cell growth and transformation, impacting cancer prognosis.
Area of Science:
- Biochemistry
- Cell Biology
- Computational Biology
Background:
- The human epidermal growth factor receptor (HER/ErbB) system, including EGFR (HER1) and HERs 2-4, is crucial for cell growth.
- Overexpression of these receptors is linked to poor outcomes in epithelial cancers.
Purpose of the Study:
- To investigate the impact of coexpressing varying levels of HERs 1-3 on receptor dimerization patterns.
- To analyze how these dimerization patterns affect cellular responses.
Main Methods:
- Utilized a detailed kinetic model for HER/ErbB dimerization and trafficking.
- Employed parameter dependence analysis for experimental design.
- Used a phenomenological model to link dimerization patterns to biological response.
Main Results:
- Coexpression of EGFR with HER2 or HER3 shifts signaling to the cell surface and slows signal downregulation.
- Simultaneous coexpression of HERs 1-3 generates abundant HER2-HER3 heterodimers, potent inducers of cell growth.
- Low to moderate EGFR, HER2, and HER3 coexpression can mimic the response of high HER2 expression.
Conclusions:
- HER/ErbB receptor coexpression significantly alters dimerization dynamics and signaling.
- HER2-HER3 heterodimers play a key role in promoting cell proliferation and transformation.
- Specific HER coexpression patterns can modulate cellular response to growth signals, with implications for cancer therapy.
More Related Videos
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018